Another promising candidate for the treatment of chronic inflammatory diseases such as JIA is the specific inhibition of SIRT1, which showed an anti-inflammatory effect in several models both in vitro and in vivo. The gene discussed is SIRT1; the disease is juvenile idiopathic arthritis.